
Category: Pharma & drug development


Understanding drug-resistant TB

How do cancer cells communicate and can it help us catch them?

Proteomics and the promise of ‘enriching’ clinical trials

Is growth factor protein the future of Parkinson’s treatment?

The drugs fighting memory loss

Medical cannabis in the UK: how has the roll out gone so far?

Thumbs up for esketamine

Access to antivenom needs attention

Developing a new class of cancer combo drugs

Is a lack of female participants skewing heart disease trial results?

Using AI to personalise drug combination therapy

Manufacturing personalised meds: what needs to change?

Gene and cell therapies: making manufacturing work

Disposable diagnostics

Philanthropy in pharma: a look inside the ISPE Foundation

The next generation of antimalarials

Could cutting out mediators let cancer research off the leash?

Cannabinoids breakthrough signals hope for epilepsy treatment
